NCT05773222View on ClinicalTrials.gov

Efficacy and Safety of Apixaban in Korean Frail Atrial Fibrillation Patient

Active, not recruitingOBSERVATIONAL

Enrollment

2,500

Participants

Timeline

Start Date

August 12, 2019

Primary Completion Date

March 4, 2022

Study Completion Date

December 31, 2026

Conditions

Atrial Fibrillation

Interventions

DRUG

Apixaban

Single Group Assignment

Trial Locations (1)

03080

Seoul National university Hostpital, Seoul

All Listed Sponsors

lead

Seoul National University Hospital

OTHER